age for glp 1 GLP-1 use peaks in middle age, then drops at 65 GLP-1 Microdosing, Brain Health &

- , - , 4

doi: 10.1089/ars.2010.3731 71 JiangS.MaphisN

Patients with diabetes and brain metastases live longer with GLP-1 therapy In a global electronic medical record study of more than 19,000 patients with diabetes whose cancers had metastasized to the brain, the 866 patients treated with GLP-1 drugs between 2018 and 2024 had lower overall mortality

Kidney Int 70:536542

Research shows that it may help protect the digestive tract (gi tract), including the gastrointestinal lining, from damage caused by nonsteroidal anti-inflammatory drugs (NSAIDs), helping to maintain gut health and function